For the quarter ending 2026-03-31, CYTK had $7,322K increase in cash & cash equivalents over the period. -$151,387K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -206,031 | -183,031 | -306,178 | -134,370 |
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | 18,816 | 16,061 | 14,995 | 13,207 |
| Stock-based compensation expense | 30,394 | 30,506 | 30,696 | 27,535 |
| Non-cash lease expense | 1,585 | 1,610 | 1,472 | 1,336 |
| Loss on disposition of property and equipment | - | 0 | - | - |
| Depreciation of property and equipment | 3,378 | 2,861 | 2,679 | 2,285 |
| Change in fair value of derivative liabilities | 1,500 | 900 | 700 | 3,000 |
| Change in fair value of liabilities related to rpi transactions | -1,600 | 13,300 | -2,800 | -14,600 |
| Realized gain on investment, net | 61 | 8 | 1 | 16 |
| Interest receivable and amortization on investments | -1,874 | -3,075 | -2,696 | -4,032 |
| Non-cash interest expense related to debt | 8,455 | 8,470 | 5,648 | 5,330 |
| Debt conversion expense | - | 0 | 121,249 | - |
| Accounts receivable | -10,937 | 15,956 | -6,602 | 6,398 |
| Prepaid and other assets | -2,057 | 4,197 | -6,277 | 4,637 |
| Inventories | 3,567 | - | - | - |
| Accounts payable | 1,519 | -309 | 6,598 | 950 |
| Deferred revenue | 41 | 0 | 268 | -51,026 |
| Accrued and other liabilities | -6,213 | 26,368 | 7,617 | 13,985 |
| Operating lease liabilities | -1,039 | -4,223 | -2,150 | -2,323 |
| Other non-current liabilities | -3,954 | -3,528 | -2,681 | -1,662 |
| Net cash used in operating activities | -145,457 | -142,651 | -107,505 | -128,236 |
| Purchases of investments | 106,516 | 345,650 | 335,452 | 222,966 |
| Investment in non-marketable equity security | 0 | 0 | 0 | 0 |
| Maturities of investments | 257,938 | 280,094 | 273,826 | 274,000 |
| Sales of investments | - | 8 | 1 | 5,992 |
| Purchases of property and equipment | 5,930 | 5,644 | 9,354 | 4,145 |
| Net cash provided by investing activities | 145,492 | -71,192 | -70,979 | 52,881 |
| Repayment of finance lease liabilities | 0 | 0 | 0 | 2 |
| Repayment of term loans | 2,735 | 2,722 | 2,709 | 2,696 |
| Repayment of convertible debt | - | 0 | 402,500 | - |
| Proceeds from issuance of convertible debt, net | - | 0 | 729,460 | - |
| Proceeds from rpi transactions | - | - | 0 | 75,000 |
| Proceeds from draw on rpi multi tranche loan | - | 175,000 | - | - |
| Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs-At The Market Offering | - | 0 | 0 | 0 |
| Proceeds from issuance of common stock related to at-the-market offering, net of issuance costs-Public Offering | - | 0 | 0 | 0 |
| Proceeds from issuance of common stock related to private placement, net of issuance costs | - | 0 | 0 | 0 |
| Proceeds from issuance of common stock under equity incentive and stock purchase plans | 11,346 | 14,648 | 6,935 | 6,745 |
| Taxes paid related to net share settlement of equity awards | 841 | 1,221 | 720 | 514 |
| Net cash provided by financing activities | 7,770 | 110,705 | 330,466 | 78,533 |
| Effect of exchange rate changes on cash | -483 | 191 | 46 | -682 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | 7,322 | -102,947 | 152,028 | 2,496 |
| Cash, cash equivalents, and restricted cash, beginning of period | 125,632 | 228,579 | 76,551 | 74,055 |
| Cash, cash equivalents, and restricted cash, end of period | 132,954 | 125,632 | 228,579 | 76,551 |
CYTOKINETICS INC (CYTK)
CYTOKINETICS INC (CYTK)